Delivery Order SPE2DB20D3101-SPE2DB25FRNL1
Award Date
6/23/25
Potential Completion Date
6/24/25
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,083.94, is for the delivery of DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a medical product. This is a firm fixed-price Delivery Order contract with an ultimate completion date of June 11, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery...
This is a $12,452.41 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of DEXAMETHASONE 4 MG/ML VIALML, a medication, with a performance period ending on June 10, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a $2,547.92 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The order is for the delivery of DEXAMETHASONE 0.5 MG/5 ML ELX 237ML, a medication, with a performance period ending on May 29, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXAMETHASONE 20 MG/5 ML VIAL 5ML medication. The contract has a firm fixed price, with a ceiling value of $3,916.14, and a period of performance through May 27, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,182.24, is for the delivery of 4,566,189,769 milliliters of dexamethasone 10 mg/mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,395.34, is for the delivery of 4567268768 - DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract has a completion date of February 14, 2025 and is a firm fixed price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of dexamethasone 20 mg/5 ml vial, a critical pharmaceutical product. The $2,376.00 firm-fixed-price contract has a performance period through September 24, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,692.09 firm fixed price contract is for the delivery of DEXAMETHASONE 4 MG/ML VIALML, a prescription medication, with a performance period ending on May 30, 2025. The contract is not designated as a set-aside and is an open competition award. Amerisourcebergen Drug Corp is the prime contractor, and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXAMETHASONE 120 MG/30 ML VL 30ML, a medical product, to support federal medical procurement needs. The contract has a ceiling value of $2,700.82 and a completion date of June 6, 2025. This award is not designated as a set-aside and is part of a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXAMETHASONE 4 MG TABLET UD 100S, a pharmaceutical product, with a ceiling value of $1,841.56 and a period of performance through June 18, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...